Interpret the Hepatitis B test panel of results to indicate which of the following stage they reflect: a. Immunity from vaccination b. Late incubation c. Never infected nor vaccinated d. Late Acute phase and resolving e. Past HBV infection and immune f. Chronic infection g. Early incubation h. Acute infection HBV DNA HBsAg HBeAg Anti-HBc IgM Total Anti-Hbc Anti HBe Anti-HBs (IgG) Patient Serologic Profile Interpretation 33. neg neg neg neg neg neg positive 34. positive positive neg neg positive positive neg 35. positive neg neg neg neg neg neg 36. positive positive neg neg neg neg neg 37. neg neg neg neg positive positive positive 38. neg neg neg neg neg neg neg 39. neg neg positive positive positive neg neg 40. positive positive positive positive positive neg neg
Added by Dana L.
Close
Step 1
If HBsAg is negative and Anti-HBs is positive, it indicates immunity from vaccination. So, the first row represents **Immunity from vaccination**. Show more…
Show all steps
Your feedback will help us improve your experience
Labs
Want to see this concept in action?
Explore this concept interactively to see how it behaves as you change inputs.
Key Concepts
Recommended Videos
Yanni D.
Hepatitis is a silent epidemic killing more people in the world than HIV and TB. It leads to the inflammation of the liver and can be caused by several different viruses. Public awareness that some forms can be sexually transmitted, while a lack of knowledge about transmission and treatment options has led to misinformation and fear about hepatitis. As a result, people often shy away from diagnosis, timely intervention and vaccine programs. As a public health official what necessary information would you provide to the general population to dispel the fear and confusion over Hepatitis A? What platforms would you use to effectively communicate your message to a diverse group of people
Madhur L.
The development of viral hepatitis subsequent to a blood transfusion can cause serious complications for a patient. The article, "Hepatitis in Patients with Acute Non-lymphatic Leukemia" (Amer. of Med. (1983): 413-421) reported that despite careful screening for those having a hepatitis antigen, viral hepatitis occurs in 7% of blood recipients. Suppose a new treatment is believed to reduce the incidence of viral hepatitis. The treatment is given to 200 blood recipients, and only 6 contract hepatitis. Does it appear that the treatment is effective? That is, is it very likely that we would observe only 6/200 contract hepatitis when 7% of the population is known to do so?
Recommended Textbooks
Biology for AP Courses
Objective Biology for NEET
Introduction to General, Organic and Biochemistry
Watch the video solution with this free unlock.
EMAIL
PASSWORD